Targeted therapies in the management of renal cell carcinoma: role of bevacizumab.

Biologics · 2008 · PMC2721410 · PMID 19707382

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Despite patients in the poor MSKCC risk category (n = 54) having improved PFS (HR = 0.81; p = 0.457), this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.